InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
75%
T+90 mean return
-2.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Kumar Rashmi, Director. Director active across 1 company, notably Myriad Genetics INC. Cumulatively, 6 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €189k. Activity tracked since 3 June 2021. The latest transaction was disclosed on 5 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
49,796 shares0Common StockSEC:0001628280-25-029972:0
7,500 shares@ US$28.01100.0% of flowCommon StockSEC:0001824720-24-000003:0
15,695 shares0Common StockSEC:0001628280-24-027332:0
15,151 shares0Common StockSEC:0001824720-23-000002:0
17,275 shares0Common StockSEC:0001628280-22-016224:0
12,848 shares0Common StockSEC:0001824720-21-000002:0
6 of 6 declarations
About Kumar Rashmi
Rashmi Kumar is a Board Member at Myriad Genetics Inc. She is involved in overseeing the company's operations and formulating strategies aimed at enhancing performance. Her expertise in the healthcare sector is beneficial for the organization.
